EFFICACY OF FILGOTINIB VS PLACEBO IN ACTIVE PSORIATIC ARTHRITIS: PATIENT-LEVEL DATA FROM EQUATOR, A RANDOMIZED, PHASE 2 STUDY

被引：1
|
作者：
Mease, Philip J. [1 ,2 ]
Gladman, Dafna D. [3 ,4 ]
van den Bosch, Filip [5 ]
Stanislavchuk, Mykola [6 ]
Rychlewska-Hanczewska, Anna [7 ]
Tasset, Chantal [8 ]
Meuleners, Luc [8 ]
Besuyen, Robin [9 ]
Gao, Jingjing [10 ]
Trivedi, Mona [10 ]
Coates, Laura C. [11 ]
Helliwell, Philip [12 ]
机构：
[1] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Univ Toronto, Toronto, ON, Canada
[4] Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada
[5] Ghent Univ Hosp, Ghent, Belgium
[6] Natl Pirogov Mem Med Univ, Vinnytsya, Ukraine
[7] Ai Ctr Med, Poznan, Poland
[8] Galapagos NV, Mechelen, Belgium
[9] Galapagos BV, Leiden, Netherlands
[10] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[11] Univ Oxford, Oxford, England
[12] Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.6064
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0109
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [1] PSAID9 IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH FILGOTINIB VS PLACEBO: RESULTS FROM EQUATOR, A RANDOMIZED, PHASE 2 STUDY
    Orbai, Ana-Maria
    Ogdie, Alexis
    Gossec, Laure
    Tillett, William
    Leung, Ying Ying
    Gao, Jingjing
    Trivedi, Mona
    Tasset, Chantal
    Meuleners, Luc
    Besuyen, Robin
    Hendrikx, Thijs
    Coates, Laura C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1265 - 1266
  • [2] EFFECT OF FILGOTINIB ON PATIENT-REPORTED OUTCOMES IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM EQUATOR, A RANDOMIZED, PHASE 2 STUDY
    Coates, Laura C.
    Mease, Philip J.
    Gladman, Dafna D.
    van den Bosch, Filip
    Tasset, Chantal
    Meuleners, Luc
    Besuyen, Robin
    Gao, Jingjing
    Trivedi, Mona
    Hendrikx, Thijs
    Helliwell, Philip
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1269 - 1270
  • [3] EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR)
    Helliwell, P.
    Van den Bosch, F.
    Coates, L. C.
    Gladman, D. D.
    Tasset, C.
    Meuleners, L.
    Gilles, L.
    Gheyle, L.
    Trivedi, M.
    Alani, M.
    Besuyen, R.
    Mease, P. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 761 - 762
  • [4] Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)
    Orbai, Ana-Maria
    Ogdie, Alexis
    Gossec, Laure
    Tillett, William
    Leung, Ying Ying
    Gao, Jingjing
    Trivedi, Mona
    Tasset, Chantal
    Meuleners, Luc
    Besuyen, Robin
    Hendrikx, Thijs
    Coates, Laura C.
    [J]. RHEUMATOLOGY, 2020, 59 (07) : 1495 - 1504
  • [5] Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial
    Mease, Philip
    Coates, Laura C.
    Helliwell, Philip S.
    Stanislavchuk, Mykola
    Rychlewska-Hanczewska, Anna
    Dudek, Anna
    Abi-Saab, Walid
    Tasset, Chantal
    Meuleners, Luc
    Harrison, Pille
    Besuyen, Robin
    Van der Aa, Annegret
    Mozaffarian, Neelufar
    Greer, Joy M.
    Kunder, Rebecca
    Van den Bosch, Filip
    Gladman, Dafna D.
    [J]. LANCET, 2018, 392 (10162): : 2367 - 2377
  • [6] Efficacy of ixekizumab in patients with psoriatic arthritis: Results of a phase 3 randomized, double-blind, active- and placebo-controlled study
    Mease, Philip
    van der Heijde, Desiree
    Ritchlin, Christopher
    Cuchacovich, Rachel
    Shuler, Catherine
    Lin, Chen-Yen
    Vangerow, Harald
    Samanta, Suvajit
    Lee, Chin
    Gladman, Dafna
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
  • [7] Efficacy and Safety Results of Guselkumab in Patients with Active Psoriatic Arthritis over 56 Weeks from a Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study
    Deodhar, Atul A.
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [8] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth C.
    [J]. LANCET, 2018, 391 (10136): : 2213 - 2224
  • [9] Effect of Filgotinib on the Complete Resolution of Enthesitis in Psoriatic Arthritis (PsA) Patients: 52-week Results from EQUATOR2
    Mease, Philip
    Coates, Laura
    Van den Bosch, Filip
    Helliwell, Philip
    Gladman, Dafna
    Gilles, Leen
    Gheyle, Lien
    Trivedi, Mona
    Alani, Muhsen
    Besuyen, Robin
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] THE EFFECT OF FILGOTINIB ON ENTHESITIS: 100-WEEK DATA FROM AN OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Helliwell, P.
    Coates, L. C.
    Van den Bosch, F.
    Gladman, D. D.
    Gheyle, L.
    Trivedi, M.
    Alani, M.
    Le Brun, F. O.
    Besuyen, R.
    Mease, P. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 792 - 793
12345